The US FDA has approved multiple NDAs and BLAs in Feb 2020, leading to treatments for patients and advances in health care The Center for Drug Evaluation and Research (CDER) […]readmore
Tags : Nurtec
Shots: The approval is based on P-III study (Study 303) and Study 201 which involves assessing of Nurtec vs PBO in patients with migraine The study resulted in well-tolerated results. […]readmore